Clinical trial
Reverse Transcriptase Inhibitors in Aicardi Goutières Syndrome
NCT03304717 is registered in ClinicalTrials.gov with Children's Hospital of Philadelphia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Reverse Transcriptase Inhibitors in Aicardi Goutières Syndrome
- Lead sponsor
- Children's Hospital of Philadelphia
- Phase
- Phase 1/2
- Overall status
- Withdrawn
- Start date
- December 31, 2025
- Completion date
- December 31, 2029
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
aicardi goutières syndrome